The 12 closest competitors and alternatives to Inotiv among medical - diagnostics & research companies — ranked by similarity to what Inotiv actually does, not by market-cap band.
Subscribe to see Inotiv’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Inotiv, Inc. provides nonclinical and analytical drug discovery and development services to the pharmaceutical and medical device industries in the United States, the Netherlands, and internationally. The company operates through two segments, Discovery and Safety Assessment (DSA) and Research Models and Services (RMS). The DMS segment manufactures scientific instruments for life sciences research and the related software for use by pharmaceutical companies, universities, government research centers, and medical research institutions under the company's BASi product line. The RMS segment engages in commercial production and sales of research models, diets, bedding, and bioproducts. The company was formerly known as Bioanalytical Systems, Inc. and changed its name to Inotiv, Inc. in March 2021. Inotiv, Inc. was incorporated in 1974 and is headquartered in West Lafayette, Indiana. On June 3, 2026, Inotiv, Inc. along with its affiliates filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the Southern District of Texas.
Inotiv is a medical - diagnostics & research company headquartered in West Lafayette, United States. It is publicly listed (NOTVQ) with a market capitalisation of $390,419. Xcout tracks 24 named people at Inotiv, including Robert W. Leasure Jr. (President, Chief Executive Officer & Director).
18 more named people on record for Inotiv, with roles, board committees and tenure — see the full roster →
5 corporate events on record, with sources — see the full timeline →
Ranked by semantic similarity — how close each company is to Inotiv by what it does, using Xcout's live company graph. Click any company for its full profile, or its competitor set.
Biotech
Charles River Laboratories International, Inc. operates as a contract research organization (CRO), providing essential preclinical services to the pharmaceutical and biotechnology industries. Its core business revolves around assisting clients with drug discovery, non-clinical development, and thorough safety testing, with its services extending globally across the United States, Europe, Canada, and the Asia Pacific region. The company organizes its diverse offerings into three principal segments: Research Models and Services (RMS), Discovery and Safety Assessment (DSA), and Manufacturing Solutions. 1. Research Models and Services (RMS): This division is a key supplier of high-quality rodent research models, including specially bred strains of rats and mice for experimental purposes. It also offers a comprehensive array of support services to help clients effectively utilize these models in their research and for the screening of potential non-clinical drug candidates. These include providing genetically engineered models, insourcing solutions for facility management, and diagnostic services for research animals. 2. Discovery and Safety Assessment (DSA): The DSA segment plays a crucial role in advancing early-stage drug pipelines. It delivers early-phase and in vivo discovery services focused on identifying and validating new therapeutic targets, chemical compounds, and antibodies. The ultimate goal is to prepare promising non-clinical drug and therapeutic candidates for subsequent safety evaluations. Additionally, this segment provides an extensive range of safety assessment services, such as toxicology, pathology, safety pharmacology, bioanalysis, drug metabolism studies, and pharmacokinetics. 3. Manufacturing Solutions: This segment addresses critical quality control requirements by offering in vitro methods for both routine and rapid testing of the quality of sterile and non-sterile pharmaceuticals, as well as consumer products. It also serves as a vital provider of specialized biologics testing, which is often outsourced by pharmaceutical and biotechnology companies. Furthermore, the segment supplies avian vaccine services, including specific-pathogen-free (SPF) fertile chicken eggs, SPF chickens, and diagnostic products, all essential for vaccine production. Beyond these specialized segments, Charles River also manages contract vivarium operations, providing crucial animal housing and care facilities for its biopharmaceutical clients. The company was founded in 1947 and is headquartered in Wilmington, Massachusetts.
Biotech
Charles River Laboratories International, Inc. is an American pharmaceutical and biotechnology contract research organisation (CRO) headquartered in Wilmington, Massachusetts, United States. Founded in 1947, the company provides preclinical and clinical laboratory services for the development of new drugs, vaccines, and medical devices. Its operations span at least 20 countries, offering research models, safety assessment, and manufacturing support services to pharmaceutical, biotechnology, and government clients.
Similar medical - diagnostics & research company
Sotera Health Company, headquartered in Broadview Heights, Ohio, delivers essential sterilization, laboratory testing, and advisory services to a global clientele spanning North America, Europe, and various international regions. The firm's sterilization capabilities encompass gamma and electron beam irradiation, alongside ethylene oxide (EO) processing. Through its Nelson Labs division, Sotera Health conducts comprehensive microbiological and analytical chemistry analyses. Additionally, it offers specialized consulting to the medical device and biopharmaceutical industries. Sotera Health serves a diverse array of sectors, including medical device manufacturers, pharmaceutical companies, producers of food and agricultural products, and various commercial, advanced, and specialty application industries. Incorporated in 2017, the company was previously known as Sotera Health Topco, Inc., adopting its current name in October 2020.
Biotechnology
B2S Holdings, Inc., operating as B2S Life Sciences, is a biotherapeutic enablement company that provides custom critical reagents, assay development, validation, sample analysis, and data analytics services. The company serves biopharmaceutical and diagnostic developers by delivering research and development solutions across the assay life cycle.
Biotech
Innovotech Inc. is a Canadian, GMP and ISO-accredited laboratory and contract research organization that provides analytical, microbiological, and regulatory testing services for the pharmaceutical, biotechnology, medical device, and nutraceutical industries. The company also develops and manufactures specialized life science products, including MBEC Assay biofilm inoculator kits and hazardous drug test kits.
Biotechnology
Organoid Therapeutics, Inc. is a biotechnology contract research organization (CRO) that provides human brain tissue models, neuronal phenotyping, drug screening, and machine learning-based analytical services. The company serves pharmaceutical, biotech, and academic researchers by conducting pre-clinical research and translational studies to evaluate drug efficacy, neurotoxicity, and neurological disease models.
Biotechnology
AnaBioTec N.V. is an independent contract analytical partner for drug development, offering CMC analytics and pre-clinical bioanalysis. Headquartered in Evergem, Belgium, the company has operated its specialized laboratories since 2014.
Biotech
Discovery Life Sciences is a life sciences company headquartered in Huntsville, Alabama, with laboratory and office footprints in regions like Greater Boston. The company accelerates scientific breakthroughs by offering specialized biospecimen and analytical services.
Biotech
Genoskin provides ex vivo human skin models, primary human mast cells, and contract research services designed to replace animal testing and improve non-clinical drug development. The company serves pharmaceutical, biotechnology, cosmetics, medical device, and academic research organizations by delivering human-relevant data for safety, efficacy, toxicology, and disease research.
Biotech
Trans Genic Inc., a Japanese enterprise, specializes in the development, distribution, and licensing of genetically engineered animals and antibodies. Its operations are structured into two primary divisions: Drug Discovery Support Business and Investment Business. Within its Drug Discovery Support segment, the company offers a comprehensive array of services. These include the synthesis and analytical assessment of glycans (or sugar chains), alongside extensive non-clinical investigations crucial for pharmaceuticals, food products, cosmetics, and various chemical compounds. The firm conducts diverse safety evaluations for both food and pharmaceutical agents, and provides vital support for bioequivalence studies, encompassing clinical trials, pharmacokinetic measurements, and the compilation of clinical trial reports. Hospital support services are also part of its offerings. Furthermore, Trans Genic performs drug efficacy and pharmacological testing, provides strategic advisory services covering mergers & acquisitions, business restructuring, and succession planning, and undertakes contract manufacturing of items such as genetically engineered mice, antibodies, protein hypers, and expression cells. It also markets mouse models, associated products, and research reagents. Established in 1998, the company was initially known as Kumamoto Immunochemical Laboratories Inc. before rebranding as Trans Genic Inc. in April 2000. Its corporate headquarters are located in Fukuoka City, Japan.
Biotech
Biocytogen provides fully human antibody discovery services and preclinical contract research organization (CRO) services. The company offers genetically engineered animal models, cell lines, gene editing services, and in vivo and in vitro pharmacology studies to support biopharmaceutical research and drug development.
Biotechnology
Ichor Biotechnologies, Inc. operates as a pre-clinical contract research organization (CRO) that provides laboratory and research services to biotechnology and pharmaceutical companies. The company offers protein services, pharmacology services, in vivo disease models, and clinical trial support to assist clients with drug discovery and development.
Search any company we track to see its competitive set.
Paste a short paragraph describing a company or product — we'll find the most similar companies we track, scored 1–100.
Funding, investors, tech stack, hiring signals, leadership and corporate events — for Inotivand every competitor above — in one live dashboard.
Subscribe to Xcout Intel →